Live feed16:56:05·1220dSECFilingvia QuantisnowDiffusion Pharmaceuticals Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Costs Associated with Exit or Disposal Activities, Leadership Update, Financial Statements and ExhibitsByQuantisnow·Wall Street's wire, on your screen.DFFN· Diffusion Pharmaceuticals Inc.Health CareOriginal source
